Niacinamide is real.
It is also oversold.

Niacinamide is the amide form of vitamin B3, and it is metabolically distinct from niacin (the form that causes flushing). Once absorbed into the skin, it serves as a precursor to NAD+ and NADP+, coenzymes involved in over 400 enzymatic reactions including DNA repair, inflammatory regulation, and sebum lipid synthesis. The reason niacinamide has such a broad list of claimed effects is that NAD+ availability touches so many cellular pathways. The reason most of those claims are weakly supported is that broad mechanism does not equal strong topical effect for any specific outcome.

For acne specifically, three mechanisms have meaningful evidence. The first is anti-inflammatory action through inhibition of pro-inflammatory cytokine release. This is the strongest evidence base and explains the head-to-head trials versus topical clindamycin, both ingredients reduce inflammation, just through different pathways. The second is sebum regulation, which a 2006 study by Draelos and colleagues quantified at roughly 30% reduction in sebum excretion rate after four weeks of 2% niacinamide use. The third is barrier support, niacinamide stimulates ceramide synthesis, which is what makes it broadly useful in moisturizers and what helps it pair well with actives that compromise the barrier.

What niacinamide does not do is exfoliate, kill bacteria, or normalize keratinocyte turnover. Those are the mechanisms that drive comedone clearance and prevent new lesions from forming, and they are the reasons salicylic acid, benzoyl peroxide, and tretinoin remain the front-line treatments. Niacinamide complements those ingredients; it does not replace them.

The trial evidence for niacinamide in acne and sebum regulation centers on 2% to 5% formulations. The 1995 Shalita trial used 4% gel, the 2006 Draelos sebum trial used 2% lotion, and most subsequent acne studies have used concentrations in this range. There is no published evidence that 10% or 20% niacinamide is more effective than 5% for any acne-related outcome, and the higher-concentration products that have proliferated in the past several years often produce more irritation without producing better data.

The 10% niacinamide products that became popular around 2018 seem to have driven a temporary spike in reports of niacinamide-related flushing, redness, and breakouts. Some of this is likely formulation-specific, high-concentration niacinamide can be unstable in some bases and degrade to nicotinic acid, which does cause flushing. Some of it is simply that concentrations beyond the studied range produce idiosyncratic reactions in some people. The clinically supported recommendation is to stay in the 2% to 5% range unless there is a specific reason to go higher.

The other practical detail is that niacinamide is a water-soluble small molecule that penetrates the stratum corneum well. This is convenient, it makes it easy to formulate and easy to absorb, but it also means it can interact with other ingredients in unpredictable ways at high concentrations. Pairing 5% niacinamide with vitamin C, retinoids, and acids in the same routine is generally well-tolerated; layering 10%+ niacinamide with aggressive actives is where reactions tend to appear.

The honest case for niacinamide in an acne routine is as a supporting ingredient: layered under or alongside an evidence-backed primary active, contributing modest improvements in inflammation, sebum, and barrier function. For someone with mild inflammatory acne, niacinamide as a primary treatment is reasonable and supported by the head-to-head trials versus clindamycin. For anyone with moderate-to-severe acne, niacinamide alone is undertreatment, the trial data does not support it as a substitute for the active that does the heavy lifting.

The strongest pairings are niacinamide with benzoyl peroxide (the niacinamide reduces irritation while complementing the antibacterial action), niacinamide with retinoids (the barrier support reduces retinization severity), and niacinamide with topical antibiotics (the combination has additive effects on inflammation). Niacinamide also has reasonable evidence for fading post-inflammatory hyperpigmentation through inhibition of melanosome transfer to keratinocytes, the same dark marks that often persist after a pimple clears.

The pairing that is overhyped is niacinamide as a "purge-prevention" ingredient when starting tretinoin. The data shows niacinamide does reduce some of the dryness and barrier compromise, but it does not prevent the keratinocyte-turnover-driven flare that defines the tretinoin purge. Patients who expect niacinamide to prevent the purge are often disappointed; patients who use it to make retinization more tolerable are often satisfied. The framing matters.

Niacinamide's effects are subtler than the front-line acne actives, which makes them harder to evaluate without structured tracking. The improvements in inflammation and sebum tend to be 20% to 30% rather than the 50%+ effects that benzoyl peroxide or tretinoin can produce, and they accumulate over weeks rather than appearing dramatically. Without a daily log, most people either credit niacinamide for improvements actually driven by other ingredients in their routine or dismiss real benefits as imagined.

The practical approach is to introduce niacinamide as a single change against a stable baseline routine. Two to four weeks of pre-introduction logging, then four to eight weeks with niacinamide added, then a comparison of severity, oiliness, and inflammation before and after. If the data shows a meaningful improvement, keep it. If it shows nothing, the ingredient is not doing anything for your skin specifically and the routine slot is better used for something else.

ClearSkin's tracking model is built around exactly this kind of N-of-1 experiment. Logging severity and inflammation alongside which products were applied gives you a way to evaluate niacinamide on your skin rather than on the manufacturer's clinical trial population. The trials say it works for the average inflammatory acne patient at 4% concentration. Your skin may behave differently, the only way to find out is to track it.